Vicente José Riera Rubio

  • Citations Per Year
Learn More
BACKGROUND The long-term effects of ossein-hydroxyapatite compound (OHC), a drug used for osteoporosis prevention, have not been previously reported. The aim of this study was to assess the long-term efficacy of OHC in postmenopausal women with bone mineral density (BMD) in the osteopenia range. METHODS We performed a retrospective 4-year follow-up study(More)
  • 1